NeuroMetrix Reports Recent Media Coverage for Quell

Loading...
Loading...
WALTHAM, Mass.--(BUSINESS WIRE)--

NeuroMetrix, Inc. NURO today reported continued strong media attention focusing on the company's innovative Quell® Wearable Pain Relief Technology. Highlights include:

Recent press coverage has reached an estimated audience of over 100MM people and included overwhelmingly positive reviews from chronic pain sufferers who tried Quell. Blogger Jennifer Kilgore, of Wear, Tear and Care summarized her experience by writing, "The Quell pain relief device means I can live more of my life."

"We are excited that Quell continues to attract the attention of high profile media outlets," said Frank McGillin, Senior Vice President and General Manager, Consumer. "The positive reviews in leading chronic pain blogs, reinforces the positive impact that Quell is making for people dealing with chronic pain."

About Quell Wearable Pain Relief Technology

Quell is an easy-to-use, over-the-counter device for relief of chronic pain. This wearable device utilizes NeuroMetrix's patented technology to provide widespread pain relief. In a recent clinical study, Quell improved chronic pain in 81% of participants. Quell is currently available through select healthcare professionals, retailers and online at www.QuellRelief.com.

About NeuroMetrix

NeuroMetrix is an innovative healthcare company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com.

NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
Neurometrix.ir@neurometrix.com

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...